Rare diseases
Investigational molecules
Locations
Long-term safety study of pelacarsen in patients with atherosclerotic cardiovascular disease who completed the Lp(a)HORIZON trial
SpainStudy of BI 765423 given by intravenous infusion for patients with idiopathic pulmonary fibrosis with or without standard treatment
SpainStudy of ABBV-CLS-628 to evaluate safety and effectiveness in adults with Autosomal Dominant Polycystic Kidney Disease
SpainStudy of ifinatamab deruxtecan alone or in combination with other treatments for patients with metastatic castration-resistant prostate cancer
SpainStudy of Durvalumab for Patients with Limited Stage Small Cell Lung Cancer After Chemoradiotherapy
SpainEffectiveness and Safety of Rezafungin in Adults with Chronic Pulmonary Aspergillosis Who Have Limited Treatment Options
SpainStudy on the Safety and Effectiveness of BNT327 and Docetaxel for Patients with Advanced Non-Small Cell Lung Cancer After Chemoimmunotherapy
SpainStudy comparing empasiprubart versus intravenous immunoglobulin for treating adults with multifocal motor neuropathy
SpainStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
SpainEvaluating Sonrotoclax Alone and Combined with Zanubrutinib for Patients with Previously Untreated or Relapsed/Refractory Waldenström Macroglobulinemia
SpainStudy of Felzartamab for Patients with Late Antibody-Mediated Rejection After Kidney Transplant
SpainStudy Comparing the Safety and Immune Response of the Investigational vYF Vaccine and Stamaril for Yellow Fever in Adults in Europe and Asia
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
